Medicine & Life Sciences
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
75%
Acute Myeloid Leukemia
74%
Amphotericin B
7%
Antifungal Agents
15%
Blast Crisis
8%
Bone Marrow
23%
Bone Marrow Examination
8%
Caspofungin
18%
Chromosomes
5%
Cytarabine
29%
Cytogenetic Analysis
7%
Drug Therapy
3%
Fine Needle Biopsy
6%
fludarabine
8%
Fluorescence In Situ Hybridization
6%
Hydroxyurea
7%
Idarubicin
9%
Imatinib Mesylate
51%
Inpatients
5%
Interphase
7%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6%
Leukocyte Transfusion
10%
liposomal amphotericin B
8%
Lung
3%
Metaphase
7%
Mitoxantrone
8%
Mucormycosis
8%
Outpatients
4%
Pancytopenia
16%
Philadelphia Chromosome
100%
Phosphotransferases
5%
Protein-Tyrosine Kinases
5%
Real-Time Polymerase Chain Reaction
5%
Therapeutics
12%
Topoisomerase II Inhibitors
9%
vatalanib
33%
Vorinostat
9%